SINCO PHARMA Publishes 2025 Annual Report and AGM Documents, Reinforces E-Communication Policy

Bulletin Express04-20

On 21 April 2026, Sinco Pharmaceuticals Holdings Limited (SINCO PHARMA) announced that its 2025 Annual Report, accompanying circular and Notice of Annual General Meeting have been released in both English and Chinese.

Key points 1. Availability of documents • Full versions of the 2025 Annual Report, circular and AGM notice can be accessed on the HKEX news website (www.hkexnews.hk) and the company’s site (www.sinco-pharm.com). • Shareholders who previously elected to receive printed materials are being mailed hard copies at no cost.

2. Electronic dissemination framework • SINCO PHARMA reconfirmed the shift to electronic distribution for all future corporate communications—including annual and interim reports, meeting notices, listing documents, circulars and proxy forms—in line with Hong Kong Listing Rules. • Both language versions will be posted online, replacing routine hard-copy dispatches.

3. Action required for non-registered shareholders • Investors holding shares through banks, brokers, custodians or other intermediaries should provide a functional email address to those intermediaries to receive timely electronic communications. • Printed copies remain available on request via email (sinco.ecom@computershare.com.hk) or by written notice to the Hong Kong share registrar, Computershare Hong Kong Investor Services Limited.

4. Contact details • Enquiries can be directed to Computershare Hong Kong Investor Services at +852 2862 8688 during business hours (09:00–18:00, Monday to Friday, excluding Hong Kong public holidays).

The initiative underscores SINCO PHARMA’s ongoing transition toward digital shareholder engagement while ensuring optional physical delivery for investors who prefer hard copies.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment